Novo Nordisk A/S - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US6701002056
35,82 € ↓ -1,80 (-4,78%)
2026-06-05
DEL PRIS
SecurityDE:NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)
InstitutionCapital Insight Partners, Llc
Latest Disclosed Ownership13,033 shares
Latest Disclosed Value $ 663,120
Capital Insight Partners, Llc reports 70.62% decrease in ownership of NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)

On February 17, 2026 - Capital Insight Partners, Llc filed a 13F-HR form disclosing ownership of 13,033 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock) (DE:NOVA) valued at $576,059 USD as of December 31, 2025. The entity filed a previous 13F-HR on October 14, 2025 disclosing 44,357 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock). This represents a change in shares of -70.62% during the quarter. The current value of the position is $466,842 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-17 2025-12-31 13F NOVO-NORDISK A S ADR 670100205 13,033 -31,324 -70.62 663 -73.06 0.1403
2025-10-14 2025-09-30 13F NOVO-NORDISK A S ADR 670100205 44,357 -6,248 -12.35 2,461 -29.52 0.4075
2025-07-17 2025-06-30 13F NOVO-NORDISK A S ADR 670100205 50,605 -4,702 -8.50 3,493 -9.06 0.6070
2025-04-30 2025-03-31 13F NOVO-NORDISK A S ADR 670100205 55,307 3,095 5.93 3,841 -14.50 0.6701
2025-01-24 2024-12-31 13F NOVO-NORDISK A S ADR 670100205 52,212 6,008 13.00 4,491 -18.36 0.7763
2024-10-09 2024-09-30 13F NOVO-NORDISK A S ADR 670100205 46,204 1,929 4.36 5,502 -12.95 0.9629
2024-07-24 2024-06-30 13F NOVO-NORDISK A S ADR 670100205 44,275 -1,129 -2.49 6,320 8.41 1.1927
2024-04-16 2024-03-31 13F NOVO-NORDISK A S ADR 670100205 45,404 674 1.51 5,830 25.98 1.0893
2024-01-24 2023-12-31 13F NOVO-NORDISK A S ADR 670100205 44,730 518 1.17 4,627 15.10 0.9464
2023-10-30 2023-09-30 13F NOVO-NORDISK A S ADR 670100205 44,212 23,125 109.66 4,021 17.82 0.9133
2023-07-24 2023-06-30 13F NOVO-NORDISK A S ADR 670100205 21,087 -206 -0.97 3,413 0.71 0.7634
2023-04-28 2023-03-31 13F NOVO-NORDISK A S ADR 670100205 21,293 548 2.64 3,389 20.70 0.7966
2023-02-07 2022-12-31 13F NOVO-NORDISK A S ADR 670100205 20,745 171 0.83 2,808 36.93 0.7281
2022-10-20 2022-09-30 13F NOVO-NORDISK A S ADR 670100205 20,574 861 4.37 2,050 -6.69 0.5524
2022-07-20 2022-06-30 13F NOVO-NORDISK A S ADR 670100205 19,713 -83 -0.42 2,197 -0.05 0.5129
2022-04-21 2022-03-31 13F NOVO-NORDISK A S ADR 670100205 19,796 -799 -3.88 2,198 -4.72 0.4484
2022-01-20 2021-12-31 13F NOVO-NORDISK A S ADR 670100205 20,595 1,024 5.23 2,307 22.78 0.4696
2021-10-13 2021-09-30 13F NOVO-NORDISK A S ADR 670100205 19,571 645 3.41 1,879 18.55 0.4084
2021-08-02 2021-06-30 13F NOVO-NORDISK A S ADR 670100205 18,926 855 4.73 1,585 30.13 0.3580
2021-04-20 2021-03-31 13F NOVO-NORDISK A S ADR 670100205 18,071 445 2.52 1,218 -1.06 0.2959
2021-02-02 2020-12-31 13F NOVO-NORDISK A S ADR 670100205 17,626 213 1.22 1,231 1.82 0.3098
2020-11-04 2020-09-30 13F NOVO-NORDISK A S ADR 670100205 17,413 -299 -1.69 1,209 4.22 0.3399
2020-07-15 2020-06-30 13F NOVO-NORDISK A S ADR 670100205 17,712 -78 -0.44 1,160 8.31 0.3659
2020-04-14 2020-03-31 13F NOVO-NORDISK A S ADR 670100205 17,790 895 5.30 1,071 9.51 0.5658
2020-01-27 2019-12-31 13F NOVO-NORDISK A S ADR 670100205 16,895 -26 -0.15 978 11.77 0.4493
2019-10-09 2019-09-30 13F Novo Nordisk A COM 670100205 16,921 -128 -0.75 875 0.57 0.7643
2019-07-09 2019-06-30 13F Novo Nordisk A COM 670100205 17,049 285 1.70 870 -0.80 0.7560
2019-04-04 2019-03-31 13F Novo Nordisk A COM 670100205 16,764 152 0.92 877 14.64 0.7924
2019-01-03 2018-12-31 13F Novo Nordisk A COM 670100205 16,612 16,612 765 0.7898
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.